1. Results Of A Comparative Analysis Of Sepsis Markers In Newborns

Authors

  • A.D. Nurakhova Kazakh Medical University of Continuing Education, Almaty, Kazakhstan
  • D.Zh. Batyrbaeva Kazakh National Medical University under the name of S.D.Asfendiyarov, Almaty, Kazakhstan
  • G.B. Abdilova National Scientific Surgery Center under the name of A.N.Syzganov, Almaty, Kazakhstan
  • A.M. Maimakova Kazakh Medical University of Continuing Education, Almaty, Kazakhstan
  • Zh.S. Alibaeva Kazakh National Medical University under the name of S.D.Asfendiyarov, Almaty, Kazakhstan
  • N.K. Ibraeva National Scientific Surgery Center under the name of A.N.Syzganov, Almaty, Kazakhstan
  • A.A. Abdraimova National Scientific Surgery Center under the name of A.N.Syzganov, Almaty, Kazakhstan

Downloads

Abstract

The paper analyzes the results of a comparative study of sepsis markers: presepsin (PSP), procalcitonin (PCT), C-reactive protein (CRP) in sepsis in newborns. The clinical application of these indicators was as-sessed, their diagnostic effectiveness and prognostic significance in the perinatal center of Almaty (Repub-lic of Kazakhstan). We have shown that when monitoring the dynamics of the development of sepsis, pre-sepsin, unlike other markers, reliably reflects the real dynamics of its severity, and quickly and adequately changes depending on the effectiveness of therapy.

Keywords

sepsis, newborns, presepsin, procalcitonin, C-reactive protein

References

  1. Kwiatkowska-Gruca M., Behrendt J., Sonsala A., et al. Presepsyna(rozpuszczalny podtyp CD14-ST) jako diagnostyczny biomarker posocznicy u noworodków. Pediatria Polska 2013;88(5):392–7
  2. Moore L.J., Moore F.A. Early diagnosis and evidence-based care of surgical sepsis. J Intensive Care Med 2013;28(2):107–117
  3. Carley Riley and Derek S. Wheeler. Prevention of Sepsis in Children: A New Paradigm for Public Policy // Critical Care Research and Practice. Volume 2012 (2012), Article ID 437139, 8 pages
  4. Hartman M.E., Linde-Zwirble W.T., Angus D.C. et al, Trends in the epidemiology of pediatric severe sep-sis. Pediatr Crit Care Med. 2013;14(7):686-93
  5. Lagu T., Rothberg M.B., Shieh M.S. et al. Hospi-talizations, costs, and outcomes of severe sepsis in the United States 2003 to
  6. Chiesa C., Natale F., Pascone R. et al. C reactive protein and procalcitonin: Reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 2011; 412(11–12):1053–9
  7. Horeczko T, Green JP, Panacek EA. Epidemiology of the Systemic Inflammatory Response Syndrome (SIRS) in the Emergency Department. West J Emerg Med. 2014;15(3):329-36
  8. Samsygina G.A. Sepsis and septic shock in new-borns. Pediatrics.
  9. Angus, R.S. Watson // Pediatr. Crit. Care Med. — 2013. — Vol. 14(7). — P.686—693
  10. Mussap M., Puxeddu E., Burrai P. et al. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. J Matern Fetal Neonatal Med 2012;25(Suppl 5):51–3
  11. Velkov V.V. Presepsin is an early and highly specific marker of sepsis: new possibilities. The scientific and practical journal “Clinical and Laboratory Consulta-tion”, No. 3-4 (50) December, 2014, p. 4-31

Published

2019-10-01

Issue

No. 3 (2019)

Section

Статьи